A New Hampshire House committee voted down a measure that would have ended water fluoridation in the state, the Concord Monitor reported Feb. 17. Four notes: 1. Fluoride is currently added to more ...

Dr. Heidenreich notes that among the 86% of seminoma CSI patients, 15-30% relapse, of which 95% relapse in the retroperitoneum, nearly all relapses have good prognosis, and these patients are now CS ...

Abridge announced a $250 million Series D fundraise co-led by investor Elad Gil and IVP with participation from many other notable venture firms. Abridge, which has emerged as one of the leaders amid ...

At ViVE 2025, digital health leaders reveal new generative AI products and industry cost savings reports. Here's a look at ...

A novel AI-assisted patient screening tool significantly improved the speed of determining eligibility and enrollment in a ...

Patients treated with tyrosine kinase inhibitors received olanzapine to address adverse effects including nausea/vomiting, ...

Health systems are rapidly testing out and scaling ambient AI tools to help clinicians with tedious documentation. This shift ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

Abridge said Monday it raised $250 million in Series D funding and announced a new artificial intelligence tool that produces ...

Abridge, the leading generative AI platform for clinical conversations, has raised a $250 million Series D investment, ...

Saint Francis Healthcare System is expanding its use of Abridge's AI platform to automate clinical documentation, reducing ...